Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Autophagy related protein 9B (ATG9B) is a vertebrate-specific, multi-spanning membrane protein that functions as a lipid scramblase and is crucial for autophagosomal membrane expansion by mediating phospholipid distribution during autophagosome formation[1][3]. While less ubiquitously expressed than its paralog ATG9A, ATG9B is particularly enriched in tissues like placenta and pituitary gland, with specialized roles in autophagy and possible compensatory activity when ATG9A is absent[1]. ATG9B cycles between the preautophagosomal structure and cytoplasmic vesicle pools, supplying membrane material vital for autophagosome biogenesis. Additionally, it modulates focal adhesion assembly and cell invasion through mechanisms that can be independent of autophagy, as evidenced in colorectal cancer where high ATG9B expression is linked with metastasis and poor patient prognosis[2]. Loss or mutation of ATG9B has been associated with various cancers and disorders reflecting its regulatory roles in both autophagic and non-autophagic processes[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autophagy related protein 9B (ATG9B).